NCT07464808 Utilizing Anti-Factor Xa as a Predictive Tool for Optimizing Outcome in Burn Patients' Management
| NCT ID | NCT07464808 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Ain Shams University |
| Condition | Venous Thromboembolic Event |
| Study Type | INTERVENTIONAL |
| Enrollment | 25 participants |
| Start Date | 2025-11-28 |
| Primary Completion | 2027-01-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 25 participants in total. It began in 2025-11-28 with a primary completion date of 2027-01-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study aims to compare the efficacy of anti-Xa based versus weight-based enoxaparin dosing and to evaluate anti-Xa levels as a predictive tool for clinical outcomes in burn patients
Eligibility Criteria
Inclusion Criteria: 1. Adults (≥21 years) admitted to the burn unit with thermal burns ≥20% TBSA and \< 60%. 2. Admission to BICU within 48 hours of burn injury. 3. Indication for VTE prophylaxis (e.g., immobilized, surgical intervention). 4. Ability to provide informed consent Exclusion Criteria: 1. Pre-existing coagulopathy or anticoagulant therapy prior to injury. 2. Patients with severe comorbidities (e.g., end-stage renal failure, advanced malignancy, hepatic disease). 3. Need for therapeutic anticoagulant therapy. 4. patients with extremes of weight, (45kg \>=weight \>= 150kg).
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07464808 clinical trial?
This trial is open to participants of all sexes, aged 21 Years or older, studying Venous Thromboembolic Event. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07464808 currently recruiting?
Yes, NCT07464808 is actively recruiting participants. Contact the research team at Doaaeldin@med.asu.edu.eg for enrollment information.
Where is the NCT07464808 trial being conducted?
This trial is being conducted at Cairo, Egypt.
Who is sponsoring the NCT07464808 clinical trial?
NCT07464808 is sponsored by Ain Shams University. The trial plans to enroll 25 participants.